HomeEXECUTIVESStrive Health Appoints Dr. Kavita Patel to its Board of Directors: A...

Strive Health Appoints Dr. Kavita Patel to its Board of Directors: A Well-Regarded Authority Across Healthcare Sections

Strive Health, the national leader in value-based kidney care, today announced that Dr. Kavita Patel has joined the company’s Board of Directors.

Strive Health notes that Dr. Kavita Patel is a primary care physician at Mary’s Center, a Federally Qualified Health Center in Washington, D.C., and a non-resident Fellow in the Department of Economic Studies at the Brookings Institution, one of the nation’s premier research and thought leadership organizations.

“Dr. Kavita Patel is a well-regarded authority across healthcare sectors,” said Chris Riopelle, Chief Executive Officer (CEO) of Strive Health. “Her deep experience will be a tremendous resource as Strive Health continues its growth in delivering transformative, value-based kidney care that improves peoples’ lives. We are excited to welcome Dr. Patel to our Board.”

Strive Health notes at the Brookings Institution, Dr. Kavita Patel is helping healthcare systems understand how to transform clinical environments to become more accountable for the care they provide as well as other aspects of health reform implementation. Dr. Patel frequently provides expert commentary to radio and print media outlets, including National Public Radio, CBS, Newsweek and MarketWatch.

She also served the Obama Administration as Director of Policy for the Office of Intergovernmental Affairs and Public Engagement in the White House, where she played a key role in designing healthcare reform legislation. As deputy staff director on health for late Senator Edward Kennedy, she served as a policy analyst and a senior staff member of the Health, Education, Labor and Pensions (HELP) Committee.

“Kidney disease impacts a substantial percentage of U.S. adults, and that percentage continues to grow,” said Dr. Patel. “Strive Health’s dedication to and knowledge of the challenges people face with this chronic condition has enabled it to innovate on the current treatment approach. I am honored to join the Board and look forward to collaborating with the team.”

Kidney disease impacts 37 million Americans, most of whom are unaware they have it. A proactive, value-based approach is required for earlier intervention that promotes patient health and well-being. Strive Health integrates technology, including proprietary machine learning algorithms, and clinical infrastructure to improve health outcomes for patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD).

Earlier this month, Strive Health also announced the appointment of Brandi Riddle as Chief Financial Officer. The company believes that transformational outcomes in kidney care are only possible through authentic diversity at all levels.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

EXECUTIVES ON THE MOVE

"We are excited to welcome Jeff Anderson to Nutjobs as our new CEO. His broad experience and tactical leadership will be instrumental in executing against our vision to provide innovative, sustainable solutions to our customers," said Paul Kephart, Co-Founder, Chief Technology Officer and Chairperson of the Nutjobs Board.
Potrero Medical believes that this voluntary reorganization will bolster its finances and facilitate its ongoing focus on elevating patient care.
Dr John Parker will work closely with PeriGen's client base to optimize use of the company's analytics for patient care and research. He will also be instrumental in informing product development and regulatory affairs as PeriGen continues to expand its product suite and associated services.
“We’re delighted to welcome Gerald and Hannah to the PrecisionLife team at a time when our deep disease insights and patient stratification biomarkers are finding important new markets and bringing precision approaches to the early, more accurate diagnosis and care of patients with complex chronic diseases,” said Dr Steve Gardner, PrecisionLife CEO.
Broken String Biosciences reports Gavin Burns will be responsible for building and optimizing the companys teams, processes, and systems.

By using this website you agree to accept Medical Device News Magazine Privacy Policy